Key stats
About GLOBAL X MARIJUANA LIFE SCIENCES IN
Expense ratio
1.01%
Home page
Inception date
Apr 4, 2017
The fund invests in equity securities as well as ADRs of companies substantially in the same proportion as its underlying index. These securities are listed on stock exchanges in North America, and are classified as life sciences companies (including those involved in biopharmaceuticals, medical manufacturing, distribution, and bio products) as well as other companies with significant business activities in the marijuana industry. Rebalanced quarterly, the portfolio is market-cap-weighted with 10% maximum capping for each constituent.
Classification
What's in the fund
Exposure type
Process Industries
Health Technology
Finance
Producer Manufacturing
Stock breakdown by region
Displays a symbol's price movements over previous years to identify recurring trends.